Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Construction of a robust prognostic model for adult adrenocortical carcinoma: Results from bioinformatics and real-world data. | J Cell Mol Med | 2021 | 33626208 | PubTator, text mining | PubMed |
| Systematic analysis of the expression and prognosis relevance of FBXO family reveals the significance of FBXO1 in human breast cancer. | Cancer Cell Int | 2021 | 33622332 | PubTator, text mining | PubMed |
| Identification and validation of a hub gene prognostic index for hepatocellular carcinoma. | Future Oncol | 2021 | 33620260 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Aerobic Exercise-Related Genes Identifies CDCA4 That Promotes the Progression of Osteosarcoma. | Front Genet | 2021 | 33613651 | PubTator, text mining | PubMed |
| Advancement and properties of circular RNAs in prostate cancer: An emerging and compelling frontier for discovering. | Int J Biol Sci | 2021 | 33613119 | PubTator, text mining | PubMed |
| Mitotic kinases as drivers of the epithelial-to-mesenchymal transition and as therapeutic targets against breast cancers. | Exp Biol Med (Maywood) | 2021 | 33601912 | PubTator, text mining | PubMed |
| RCL1 copy number variants are associated with a range of neuropsychiatric phenotypes. | Mol Psychiatry | 2021 | 33597717 | PubTator, text mining | PubMed |
| Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer. | Technol Cancer Res Treat | 2021 | 33596783 | PubTator, text mining | PubMed |
| Differential requirements for the CENP-O complex reveal parallel PLK1 kinetochore recruitment pathways. | Mol Biol Cell | 2021 | 33596090 | PubTator, text mining | PubMed |
| BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma. | Oncology | 2021 | 33588420 | PubTator, text mining | PubMed |
| Arsenic hexoxide has differential effects on cell proliferation and genome-wide gene expression in human primary mammary epithelial and MCF7 cells. | Sci Rep | 2021 | 33580144 | PubTator, text mining | PubMed |
| Screening and identification of hub genes in bladder cancer by bioinformatics analysis and KIF11 is a potential prognostic biomarker. | Oncol Lett | 2021 | 33574944 | PubTator, text mining | PubMed |
| Sinomenine Inhibits the Growth of Ovarian Cancer Cells Through the Suppression of Mitosis by Down-Regulating the Expression and the Activity of CDK1. | Onco Targets Ther | 2021 | 33574676 | PubTator, text mining | PubMed |
| Therapeutic Targeting PLK1 by ON-01910.Na Is Effective in Local Treatment of Retinoblastoma. | Oncol Res | 2021 | 33573708 | PubTator, text mining | PubMed |
| DIscBIO: A User-Friendly Pipeline for Biomarker Discovery in Single-Cell Transcriptomics. | Int J Mol Sci | 2021 | 33573289 | PubTator, text mining | PubMed |
| Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. | Cell | 2021 | 33571429 | PubTator, text mining | PubMed |
| A prognostic nomogram for lung adenocarcinoma based on immune-infiltrating Treg-related genes: from bench to bedside. | Transl Lung Cancer Res | 2021 | 33569302 | PubTator, text mining | PubMed |
| The long noncoding RNA CRYBG3 induces aneuploidy by interfering with spindle assembly checkpoint via direct binding with Bub3. | Oncogene | 2021 | 33564066 | PubTator, text mining | PubMed |
| Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. | Int J Mol Sci | 2021 | 33562824 | PubTator, text mining | PubMed |
| Understanding How Genetic Mutations Collaborate with Genomic Instability in Cancer. | Cells | 2021 | 33562057 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=59